Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP-9

To investigate the inhibitory specificity of angiotensin converting enzyme (ACE) inhibitors to matrix metal loproteinase (MMP)-9, we predicted molecular interactions between an ACE inhibitor imidapril and MPAP-9 active site based on recent X-ray structural analyses. Two binding modes differing in the orientation of imidapril on the active site were identified, and its hydrophobic group appeared to preferentially interact with the S1 site compared with the S F site. Compared with the lisinopril-NINIP-9 model in our previous study, imidapril was stabilized effectively on the active site with less of molecular distortions. We also measured ACE and MMP-9 inhibitory activities of imidapril and lisinopril after myocardial infarction. Imidapril had a stronger inhibitory activity against MMP-9 than lisinopril. These findings show that imidapril inhibits MMP-9 directly like lisinopril and its hydrophobic interactions with the SI site of MMP-9 would be important for enhancing inhibitory activity(-). (c) 2007 Elsevier Inc. All rights reserved.